OLEMA PHARMACEUTICALS INC has a total of 50 patent applications. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FAUSTUS FORSCHUNGS CIE, THAR PHARMACEUTICALS INC and REDOX PHARMA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | African Regional Industrial Property Organization | 2 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Chile | 2 | |
#9 | China | 2 | |
#10 | Israel | 2 | |
#11 | Japan | 2 | |
#12 | Republic of Korea | 2 | |
#13 | Mexico | 2 | |
#14 | Argentina | 1 | |
#15 | Costa Rica | 1 | |
#16 | Dominican Republic | 1 | |
#17 | Hong Kong | 1 | |
#18 | Morocco | 1 | |
#19 | Republic of Moldova | 1 | |
#20 | Nicaragua | 1 | |
#21 | Peru | 1 | |
#22 | Philippines | 1 | |
#23 | Russian Federation | 1 | |
#24 | Singapore | 1 | |
#25 | Tunisia | 1 | |
#26 | Taiwan | 1 | |
#27 | Ukraine | 1 | |
#28 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds | |
#5 | Peptides | |
#6 | Enzymes | |
#7 | Microorganisms | |
#8 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kushner Peter J | 39 |
#2 | Harmon Cyrus L | 39 |
#3 | Myles David C | 37 |
#4 | Gallagher Leslie Carol Hodges | 20 |
#5 | Peter J Kushner | 6 |
#6 | David C Myles | 6 |
#7 | Gallagher Leslie Hodges | 6 |
#8 | Cyrus L Harmon | 6 |
#9 | Sun Richard | 3 |
#10 | Leslie Carol Hodges Gallagher | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021007146A1 | Regimens of estrogen receptor antagonists | |
WO2018157000A1 | Compositions and methods for regulating immune system activity | |
WO2017059139A1 | TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS | |
WO2014203132A1 | Substituted benzopyran compounds, compositions and uses thereof | |
WO2014203129A1 | Combinations of benzopyran compounds, compositions and uses thereof | |
AP2014007657A0 | Novel benzopyran compounds, compositions and uses thereof | |
WO2011129837A1 | Use of a 4-hydroxytoremifene prodrug for treatment of breast cancer |